2260669-49-4
2260669-49-4
Chemical Structure
Monoolein-d7
- CAS No.: 2260669-49-4
- Formula:C21H33D7O4
- Molecular Weight:363.58
IUPAC Name: 2,3-dihydroxypropyl (Z)-octadec-9-enoate-16,16,17,17,18,18,18-d7
InChIKey: RZRNAYUHWVFMIP-IJGLUQEOSA-N
SMILES: OCC(O)COC(CCCCCCC/C=C\CCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=O
Biological Activity: Monoolein-d7 is deuterium labeled Monoolein. Monoolein is an endogenous metabolite.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Monoolein-d7 | 99.0% | Monoolein-d7 is deuterium labeled Monoolein. Monoolein is an endogenous metabolite. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Monoolein (Standard) | ≥98% | Monoolein is a biocompatible lipid molecule that can be used as a carrier for bone repair. Monoolein exhibits anti-inflammatory activity by inhibiting the immune response induced by LPS (HY-D1056). It exerts its anti-inflammatory effects by reducing the production of immune response factors such as IL-12 p40, IL-6, and TNF-α, and inhibiting the generation of NO. Monoolein can be used in drug delivery and research in the field of inflammatory diseases . | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Monoolein-d5 | 99.94% | Monoolein-d5 is the deuterium labeled Monoolein. Monoolein is an endogenous metabolite. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Monoolein | 99.9% | Monoolein is a biocompatible lipid molecule that can be used as a carrier for bone repair. Monoolein exhibits anti-inflammatory activity by inhibiting the immune response induced by LPS (HY-D1056). It exerts its anti-inflammatory effects by reducing the production of immune response factors such as IL-12 p40, IL-6, and TNF-α, and inhibiting the generation of NO. Monoolein can be used in drug delivery and research in the field of inflammatory diseases . | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
